View in EDS HTML Full Text PDF Full Text

Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?

Saved in:
Bibliographic Details
Title: Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?
Authors: Chuquilin M; Department of Neurology, University of Florida, Gainesville., Barohn R; Department of Neurology, University of Missouri School of Medicine, Columbia.
Source: JAMA neurology [JAMA Neurol] 2022 Nov 01; Vol. 79 (11), pp. 1100-1102.
Publication Type: Editorial; Comment
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36121665
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chuquilin+M%22">Chuquilin M</searchLink>; Department of Neurology, University of Florida, Gainesville.<br /><searchLink fieldCode="AU" term="%22Barohn+R%22">Barohn R</searchLink>; Department of Neurology, University of Missouri School of Medicine, Columbia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589536%22">JAMA neurology</searchLink> [JAMA Neurol] 2022 Nov 01; Vol. 79 (11), pp. 1100-1102.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589536 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686149%22">21686149 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Neurol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36121665
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaneurol.2022.2311
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1100
    Titles:
      – TitleFull: Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chuquilin M
      – PersonEntity:
          Name:
            NameFull: Barohn R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2022 Nov 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6157
          Numbering:
            – Type: volume
              Value: 79
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: JAMA neurology
              Type: main
ResultId 1